Symposium:
110. The Changing Face of Endocarditis
Saturday, October 22, 2011: 8:15 AM-9:45 AM
Room: 253ABC

Learning Objectives:

At the end of this session attendees will be able to:

  • discuss the causes and complications of staphylococcal endocarditis
  • identify new strategies for treatment of patients with staphylococcal and non-staphylococcal endocarditis

Target Audience: Pharmacists, Clinicians, Academicians

Tracks: Adult ID

Moderators:  Robert Read, MD, FIDSA, University of Sheffield and Sheffield Teaching Hospitals Sheffield and Vance Fowler, MD, Duke University Medical Center

CME Credits: Maximum of 1.5 hours of Category 1 credit possible

ACPE Credits: ACPE 1.5 knowledge-based contact hours (0.15 CEU) of Pharmacy CE

ACPE Number: 0461-9999-11-157-L01-P

Disclosures:

R. Read, None

V. Fowler, Astellas, Cubist, Inhibitex, Merck, Johnson & Johnson, Leo Pharmaceuticals, NovaDigm, The Medicines Company, Baxter Pharmaceuticals, Biosynexus, Shire, Inimex, Galderma : Consultant, Consulting fee
NIH Astellas Cubist Merck Theravance Cerexa Pfizer Novartis Advanced Liquid Logic Inhibitex : Grant Investigator, Grant recipient
UpTo Date: Member, Licensing agreement or royalty
Arpida Astellas Cubist Inhibitex Merck Pfizer Targanta Theravance Wyeth Ortho-McNeil Novartis Vertex Pharmaceuticals Medimmune: speaker, Speaker honorarium

J. M. Miro, Novartis: Grant Investigator and Scientific Advisor, Consulting fee, Research grant and Speaker honorarium
Cubist: Grant Investigator and Scientific Advisor, Consulting fee, Research grant and Speaker honorarium
Pfizer: Grant Investigator, Research grant
Theravance: Grant Investigator, Research grant and Speaker honorarium

V. Fowler, Astellas, Cubist, Inhibitex, Merck, Johnson & Johnson, Leo Pharmaceuticals, NovaDigm, The Medicines Company, Baxter Pharmaceuticals, Biosynexus, Shire, Inimex, Galderma : Consultant, Consulting fee
NIH Astellas Cubist Merck Theravance Cerexa Pfizer Novartis Advanced Liquid Logic Inhibitex : Grant Investigator, Grant recipient
UpTo Date: Member, Licensing agreement or royalty
Arpida Astellas Cubist Inhibitex Merck Pfizer Targanta Theravance Wyeth Ortho-McNeil Novartis Vertex Pharmaceuticals Medimmune: speaker, Speaker honorarium

B. Murray, Astellas: Grant Investigator, Research support
Johnson & Johnson: Grant Investigator, Research grant
Intercell: Grant Investigator, Research grant
Cubist: Grant Investigator, Research grant
Durata Therapeutics: Board Member and Consultant, Consulting fee
Rib-X: Board Member and Consultant, Consulting fee
The Medicines Company: Board Member and Consultant, Consulting fee
Pfizer/Wyeth: Board Member and Consultant, Consulting fee

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. EST Thursday, Oct. 20 with the exception of research findings presented at IDSA press conferences.